SK286112B6 - Aminoderiváty biotínu a ich konjugáty s makrocyklickými chelátovými činidlami, farmaceutický a/alebo diagnostický prípravok s ich obsahom a použitie týchto derivátov - Google Patents

Aminoderiváty biotínu a ich konjugáty s makrocyklickými chelátovými činidlami, farmaceutický a/alebo diagnostický prípravok s ich obsahom a použitie týchto derivátov Download PDF

Info

Publication number
SK286112B6
SK286112B6 SK1115-2003A SK11152003A SK286112B6 SK 286112 B6 SK286112 B6 SK 286112B6 SK 11152003 A SK11152003 A SK 11152003A SK 286112 B6 SK286112 B6 SK 286112B6
Authority
SK
Slovakia
Prior art keywords
group
biotin
hydrogen
compound
formula
Prior art date
Application number
SK1115-2003A
Other languages
English (en)
Slovak (sk)
Other versions
SK11152003A3 (sk
Inventor
Giovanni Paganelli
Marco Chinol
Mauro Ginanneschi
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of SK11152003A3 publication Critical patent/SK11152003A3/sk
Publication of SK286112B6 publication Critical patent/SK286112B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
SK1115-2003A 2001-02-16 2002-02-15 Aminoderiváty biotínu a ich konjugáty s makrocyklickými chelátovými činidlami, farmaceutický a/alebo diagnostický prípravok s ich obsahom a použitie týchto derivátov SK286112B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001RM000079A ITRM20010079A1 (it) 2001-02-16 2001-02-16 Amminoderivati della biotina e loro coniugati con chelanti macrociclici.
PCT/IT2002/000091 WO2002066075A2 (en) 2001-02-16 2002-02-15 Biotin-derivatives and their conjugates with chelating agents

Publications (2)

Publication Number Publication Date
SK11152003A3 SK11152003A3 (sk) 2004-02-03
SK286112B6 true SK286112B6 (sk) 2008-03-05

Family

ID=11455227

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1115-2003A SK286112B6 (sk) 2001-02-16 2002-02-15 Aminoderiváty biotínu a ich konjugáty s makrocyklickými chelátovými činidlami, farmaceutický a/alebo diagnostický prípravok s ich obsahom a použitie týchto derivátov

Country Status (19)

Country Link
US (2) US7390828B2 (pl)
EP (1) EP1359943B1 (pl)
JP (1) JP4469133B2 (pl)
KR (1) KR100860062B1 (pl)
CN (1) CN100457192C (pl)
AT (1) ATE306283T1 (pl)
AU (1) AU2002237517B2 (pl)
BR (1) BR0207327A (pl)
CZ (1) CZ305442B6 (pl)
DE (1) DE60206599T2 (pl)
DK (1) DK1359943T3 (pl)
ES (1) ES2248522T3 (pl)
HK (1) HK1068251A1 (pl)
HU (1) HU229160B1 (pl)
IT (1) ITRM20010079A1 (pl)
MX (1) MXPA03007317A (pl)
PL (1) PL202898B1 (pl)
SK (1) SK286112B6 (pl)
WO (1) WO2002066075A2 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20030196A1 (it) * 2003-04-24 2004-10-25 Sigma Tau Ind Farmaceuti Uso di reagenti per la preparazione di un medicamento
ITRM20040105A1 (it) 2004-02-27 2004-05-27 Tecnogen Scpa Anticorpo monoclonale antitenascina umana.
ITRM20050345A1 (it) * 2005-06-30 2007-01-01 Sigma Tau Ind Farmaceuti Sintesi di deossi-biotinil esametilen diammina-dota.
TWI381852B (zh) 2005-09-27 2013-01-11 Sigma Tau Ind Farmaceuti 生物素二胺基衍生物類及其與大環螯合劑之共軛物
WO2008122551A2 (en) 2007-04-04 2008-10-16 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Anti-epcam antibody and uses thereof
GB0922369D0 (en) 2009-12-22 2010-02-03 Hammersmith Imanet Ltd Labelled biotin conjugates
CA2812320A1 (en) * 2010-10-22 2012-04-26 Universite De Strasbourg Pochoxime conjugates useful for the treatment of hsp90 related pathologies
US9872831B2 (en) 2011-08-02 2018-01-23 Alfasigma S.P.A. Pharmaceutical composition of oxidised avidin suitable for inhalation

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6416738B1 (en) * 1973-12-07 2002-07-09 Neorx Corporation Pretargeting methods and compounds
US6075010A (en) * 1992-06-09 2000-06-13 Neorx Corporation Small molecular weight ligand-hexose containing clearing agents
US5283342A (en) 1992-06-09 1994-02-01 Neorx Corporation Biotinylated small molecules
DE3713842A1 (de) * 1987-04-22 1988-11-17 Schering Ag Substituierte cyclische komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
IT1245748B (it) 1990-12-21 1994-10-14 Mini Ricerca Scient Tecnolog Preparazione includente anticorpi monoclonali biotinilati, avidina e biotina, per la diagnosi di affezioni tumorali e suo impiego
US5911969A (en) * 1992-06-09 1999-06-15 Neorx Corporation Pretargeting protocols for enhanced localization of active agents to target sites
US5624896A (en) * 1992-06-09 1997-04-29 Neorx Corporation Clearing agents useful in pretargeting methods
US5914312A (en) * 1992-06-09 1999-06-22 Neorx Corporation Pretargeting methods and compounds
US5616690A (en) * 1992-06-09 1997-04-01 Neorx Corporation Hexose derivatized human serum albumin clearing agents
ATE210464T1 (de) * 1992-06-09 2001-12-15 Neorx Corp BIOTIN-DOTA KONJUGATE UND DEREN VERWENDUNG IN ßPRETARGETINGß VERFAHREN
US5976535A (en) * 1992-06-09 1999-11-02 Neorx Corporation Pretargeting protocols for the enhanced localization of cytotoxins to target sites and cytotoxic combinations useful therefore
US5541287A (en) * 1992-06-09 1996-07-30 Neorx Corporation Pretargeting methods and compounds
US6217869B1 (en) * 1992-06-09 2001-04-17 Neorx Corporation Pretargeting methods and compounds
US6358490B2 (en) * 1992-06-09 2002-03-19 Neorx Corporation Three-step pretargeting methods and compounds
US5578287A (en) * 1992-06-09 1996-11-26 Neorx Corporation Three-step pretargeting methods using improved biotin-active agent
US6120768A (en) * 1993-05-17 2000-09-19 Immunomedics, Inc. Dota-biotin derivatives
JPH0730748U (ja) * 1993-11-29 1995-06-13 花王株式会社 歯ブラシ
US5955605A (en) 1995-02-21 1999-09-21 Neorx Corporation Biotinidase resistant biotin-DOTA conjugates
CA2232411A1 (en) * 1995-09-18 1997-03-27 Mallinckrodt Medical, Inc. (radio) labelled biotin derivatives
JP3427871B2 (ja) 1996-06-24 2003-07-22 戸田工業株式会社 コバルト被着型針状磁性酸化鉄粒子粉末
US6005083A (en) 1997-03-28 1999-12-21 Neorx Corporation Bridged aromatic substituted amine ligands with donor atoms

Also Published As

Publication number Publication date
CZ20031989A3 (cs) 2004-02-18
KR20030072627A (ko) 2003-09-15
CZ305442B6 (cs) 2015-09-23
US20040067199A1 (en) 2004-04-08
ITRM20010079A1 (it) 2002-08-16
WO2002066075A2 (en) 2002-08-29
DK1359943T3 (da) 2006-01-02
US20080085239A1 (en) 2008-04-10
HUP0303151A2 (hu) 2003-12-29
AU2002237517B2 (en) 2006-11-30
US7390828B2 (en) 2008-06-24
JP2004524305A (ja) 2004-08-12
ES2248522T3 (es) 2006-03-16
CN100457192C (zh) 2009-02-04
DE60206599T2 (de) 2006-06-22
CN1531445A (zh) 2004-09-22
PL202898B1 (pl) 2009-08-31
HU229160B1 (hu) 2013-09-30
MXPA03007317A (es) 2004-06-30
ITRM20010079A0 (it) 2001-02-16
KR100860062B1 (ko) 2008-09-24
EP1359943A2 (en) 2003-11-12
JP4469133B2 (ja) 2010-05-26
US8044081B2 (en) 2011-10-25
ATE306283T1 (de) 2005-10-15
BR0207327A (pt) 2004-02-10
HK1068251A1 (en) 2005-04-29
EP1359943B1 (en) 2005-10-12
DE60206599D1 (de) 2005-11-17
HUP0303151A3 (en) 2010-01-28
WO2002066075A3 (en) 2003-01-30
SK11152003A3 (sk) 2004-02-03
PL365279A1 (pl) 2004-12-27

Similar Documents

Publication Publication Date Title
US6359111B1 (en) Opioid receptor targeting
US8044081B2 (en) Aminoderivative of biotin and their conjugates with macrocyclic chelating agents
CA3222226A1 (en) Trislinker-conjugated dimeric labeling precursors and radiotracers derived therefrom
KR101301549B1 (ko) 바이오틴 다이아미노유도체 및 이들의 거대고리킬레이트제와의 접합체
AU2002237517A1 (en) Biotin-derivatives and their conjugates with chelating agents
CA2436242C (en) Biotin-derivatives and their conjugates with chelating agents

Legal Events

Date Code Title Description
PC4A Assignment and transfer of rights

Owner name: ALFASIGMA S.P.A., MILANO (MI), IT

Free format text: FORMER OWNER: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A., ROMA, IT

Effective date: 20180209

MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20210215